US big pharma sector poised to hike prices in Europe – FT

Major drugmakers are reportedly looking to maintain profits amid an initiative to charge Americans less

US pharmaceutical giants are seeking to circumvent US President Donald Trump’s campaign to lower drug costs for Americans, which may cost Europeans access to medicine, the Financial Times reported on Sunday.

Since last year, Trump has pressured big pharma to benchmark key medicines sold in the US to prices in other countries, citing unfair pricing differences.